BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AB Science 

3, Avenue George V

Paris    75008  France
Phone: 33-(0)1-47200014 Fax: 33-(0)1-47202411


SEARCH JOBS




Industry
Pharmaceutical






 Company News
AB Science (AB.PA): The Data And Safety Monitoring Board Recommends The Continuation Of The Phase 2 Study With Masitinib In Advanced Hepatocellular Carcinoma 11/12/2014 10:30:17 AM
AB Science (AB.PA): Masitinib In Mastocytosis - Summary Of Web Conference 11/10/2014 10:01:22 AM
AB Science (AB.PA): Web Conference On Masitinib In Mastocytosis 11/3/2014 8:28:41 AM
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014 7:23:56 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/21/2014 8:51:42 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/20/2014 8:58:25 AM
AB Science (AB.PA) Announces Initiation Of A New Phase 3 Study In Oncology With Masitinib In Patients With Metastatic Colorectal Cancer 12/3/2013 9:46:01 AM
AB Science (AB.PA): Final Results Of Phase 3 Mastocytosis Study Expected By End Of 2014 11/12/2013 1:36:49 PM
AB Science (AB.PA): Masitinib Successfully Passes Futility Analysis in Pivotal Clinical Study in Mastocytosis 11/11/2013 11:30:16 AM
AB Science (AB.PA) Release: Masitinib is Being Investigated in the Treatment of Amyotrophic Lateral Sclerosis (ALS) 11/5/2013 9:53:45 AM
123